BioSpace News Archive

Press Releases

Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement

July 3, 2025
·
6 min read
Press Releases

IDMC Provides Positive Recommendation for Bio-Thera Solution’s BAT4406F (ADCC-Enhanced Anti-CD20 mAb) in Neuromyelitis Optica Spectrum Disorder Based on Interim Analysis of Pivotal Phase II/III Trial

July 3, 2025
·
5 min read
Press Releases

PharmaTher Announces Path to Ketamine Commercialization with No Planned Financing, Confirms FDA Approval Goal Date of August 9th, 2025 for Ketamine

July 3, 2025
·
7 min read
Press Releases

Pneumagen Announces Peer-Reviewed Publication of Positive Phase II Study Data Highlighting the Potential of Neumifil, a Novel Broad-Spectrum Antiviral

July 3, 2025
·
3 min read
Press Releases

Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million

July 3, 2025
·
3 min read
Press Releases

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

July 3, 2025
·
3 min read
Press Releases

Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025

July 3, 2025
·
1 min read
Press Releases

CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

July 3, 2025
·
8 min read
Press Releases

BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven

July 3, 2025
·
4 min read
Press Releases

VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202

July 3, 2025
·
7 min read